organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
ºÚÁÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Articles published in Clinical Pharmacology & Biopharmaceutics have been cited by esteemed scholars and scientists all around the world. Clinical Pharmacology & Biopharmaceutics has got h-index 14, which means every article in Clinical Pharmacology & Biopharmaceutics has got 14 average citations.
Following are the list of articles that have cited the articles published in Clinical Pharmacology & Biopharmaceutics.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|---|
Total published articles |
81 | 83 | 60 | 60 | 23 | 12 | 9 | 17 | 19 |
Research, Review articles and Editorials |
54 | 44 | 38 | 14 | 18 | 3 | 0 | 0 | 0 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
23 | 19 | 9 | 18 | 2 | 5 | 0 | 0 | 0 |
Conference proceedings |
0 | 4 | 24 | 0 | 0 | 53 | 29 | 71 | 85 |
Citations received as per Google Scholar, other indexing platforms and portals |
84 | 109 | 111 | 125 | 107 | 115 | 85 | 82 | 93 |
Journal total citations count | 790 |
Journal impact factor | 1.91 |
Journal 5 years impact factor | 3.15 |
Journal cite score | 2.77 |
Journal h-index | 14 |
Journal h-index since 2019 | 11 |
Alare K, Alare T. Review of Toxicity of Allicin From Garlic. |
|
| | | |
González-Pérez M, ColÃÂn-Ortega JC, Elizabeth E. ANALYSIS OF CHEMICAL-QUANTUM INTERACTIONS BETWEEN QUERCETIN, SARS-COV-2 PROTEINS, AND COVID-19. world. 2021 Jun 8;5:9. |
|
| | | |
Alare K, Adetunji B, Alare T. Anticholinesterase Activities: The Possible Mechanism Suggestive Of Therapeutic Effect of Allicin in Garlic on Intestinal Neuronal Dysplasia Type B. J Gastrointest Dig Syst. 2021;11(6):650. |
|
| | | |
Thiyagarajan A, Bhattacharya S, Sharma N, Srivastava A, Dhar DK. Need for a universal thalassemia screening programme in India? A public health perspective. Journal of family medicine and primary care. 2019 May;8(5):1528. |
|
| | | |
Bulbul IJ, Uddin ME, Nahar N, Kuddus MR, Haque MR, Rashid MA. Antidiarrheal Activity of Four Different Species of Litsea Available in Bangladesh. Biomedical and Pharmacology Journal. 2021 Sep 1;14(3):1259-67. |
|
| | | |
Hossen MF, Hossain S, Ahamed MI, Patwary MS, Imtiaz O, Hasan M, Al Mahmud A. Evaluation of in vivo analgesic, antiemetic and anxiolytic effect of methanolic extract of Litsea monopetala in animal model. Discovery Phytomedicine. 2019;6(3):126-9. |
|
| | | |
Bulbul IJ, Rashid MA, Haque MR. Pharmacological Studies of Different Fractions of Litsea monopetala Roxb. Bangladesh Pharmaceutical Journal. 2020 Feb 3;23(1):61-4. |
|
| | | |
Al Mahmud A. Evaluation of in vivo analgesic, antiemetic and anxiolytic effect of methanolic extract of Litsea monopetala in animal model. |
|
| | | |
Al-Achi AJ. A brief review of pharmaceutics. Journal of Drug Discovery, Development and Delivery. 2020;6(1):1036. |
|
| | | |
Umar AK, Wathoni N, Hasanah AN, Kurniawansyah IS, Abdassah M. Kahar method: A novel calculation method of tonicity adjustment. Journal of pharmacy & bioallied sciences. 2019 Dec;11(Suppl 4):S635. |
|
| | | |
Karkossa F, Lehmann N, Klein S. A systematic approach for assessing the suitability of enteral feeding tubes for the administration of controlled-release pellet formulations. International Journal of Pharmaceutics. 2021 Nov 11:121286. |
|
| | | |
Lopes-Coelho F, Martins F, Hipólito A, Mendes C, Sequeira CO, Pires RF, Almeida AM, Bonifácio VD, Pereira SA, Serpa J. The Activation of Endothelial Cells Relies on a Ferroptosis-Like Mechanism: Novel Perspectives in Management of Angiogenesis and Cancer Therapy. Frontiers in Oncology. 2021 May 10;11:1666. |
|
| | | |
Turner AJ, Aggarwal P, Boone EC, Haidar CE, Relling MV, Derezinski AD, Broeckel U, Gaedigk A. Identification of CYP2D6 Haplotypes that Interfere with Commonly Used Assays for Copy Number Variation Characterization. The Journal of Molecular Diagnostics. 2021 May 1;23(5):577-88. |
|
| | | |
Ayano G. Psychotropic medications metabolized by cytochromes P450 (CYP) 2D6 enzyme and relevant drug interactions. Clin Pharmacol Biopharm. 2016;5(4):1000162. |
|
| | | |
Thakur A, Tan Z, Kameyama T, El-Khateeb E, Nagpal S, Malone S, Jamwal R, Nwabufo CK. Bioanalytical strategies in drug discovery and development. Drug Metabolism Reviews. 2021 Jul 3;53(3):434-58. |
|
| | | |
Al-Shehri MM, El-Gendy MA, Darwish IA. Development of specific new ELISA for bioanalysis of cetuximab: a monoclonal antibody used for cancer immunotherapy. Current Pharmaceutical Analysis. 2018 Sep 1;14(5):519-25. |
|
| | | |
Iwamoto N, Yokoyama K, Takanashi M, Yonezawa A, Matsubara K, Shimada T. Verification between original and biosimilar therapeutic antibody infliximab using nSMOL coupled LC-MS bioanalysis in human serum. Current pharmaceutical biotechnology. 2018 May 1;19(6):495-505. |
|
| | | |
Iwamoto N, Yokoyama K, Takanashi M, Yonezawa A, Matsubara K, Shimada T. Verification between original and biosimilar therapeutic antibody infliximab using nSMOL coupled LC-MS bioanalysis in human serum. Current pharmaceutical biotechnology. 2018 May 1;19(6):495-505. |
|
| | | |
Iwamoto N, Takanashi M, Hamada A, Shimada T. Multiplex LCMS bioanalysis of brentuximab vedotin, rituximab and cetuximab towards therapeutic drug monitoring application by combined calibration curve using fab?selective limited proteolysis nSMOL. Clin Pharmacol Biopharm. 2016;5(4):1-9. |
|
| | | |
Kantah M, Singh B, Sweed H, Neto GB, Kumar N, Chueire FB, Marotta F, Lorenzetti A, Bellow R, Solimene U. Beneficial effect of a multifunctional polyphytocompound in experimental prostatic hyperplasia in rats. Clinical Pharmacology & Biopharmaceutics. 2017;6(2):1-7. |
|
| | | |
Make the best use of Scientific Research and information from our 700 + peer reviewed, ºÚÁÏÍø Journals